Key Points
- Insider sale: Molina Healthcare insider Jeff Barlow sold 17,811 shares on May 11 for about $3.3 million, reducing his stake by roughly 21%.
- Earnings beat: The company reported quarterly EPS of $2.35, well above the consensus estimate of $1.57, though revenue of $10.80 billion came in slightly below expectations and was down 3.1% year over year.
- Mixed Wall Street view: Analyst opinions remain cautious overall, with the stock carrying an average Hold rating and a consensus price target of $174.53, even as some firms recently raised their targets.
Molina Healthcare, Inc (NYSE:MOH - Get Free Report) insider Jeff Barlow sold 17,811 shares of the business's stock in a transaction on Monday, May 11th. The shares were sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Molina Healthcare Stock Up 0.3%
Molina Healthcare stock opened at $192.11 on Thursday. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $327.68. The firm's fifty day moving average is $155.42 and its 200 day moving average is $158.55. The company has a market capitalization of $10.01 billion, a PE ratio of 56.84 and a beta of 0.85.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. During the same quarter in the prior year, the company posted $6.08 earnings per share. The business's revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, sell-side analysts predict that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.
Analyst Ratings Changes
Several research firms have weighed in on MOH. Zacks Research upgraded shares of Molina Healthcare from a "strong sell" rating to a "hold" rating in a report on Monday, April 20th. Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $129.00 price objective on shares of Molina Healthcare in a report on Friday, April 24th. Barclays upped their price objective on shares of Molina Healthcare from $133.00 to $161.00 and gave the stock an "underweight" rating in a report on Friday, April 24th. Sanford C. Bernstein restated an "outperform" rating on shares of Molina Healthcare in a report on Friday, March 13th. Finally, Mizuho lowered their price objective on shares of Molina Healthcare from $220.00 to $180.00 and set an "outperform" rating on the stock in a report on Thursday, March 12th. Three research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $174.53.
Check Out Our Latest Stock Report on Molina Healthcare
More Molina Healthcare News
Here are the key news stories impacting Molina Healthcare this week:
- Positive Sentiment: Truist Financial raised its price target on Molina Healthcare to $205, while Cantor Fitzgerald lifted its target to $209, signaling continued analyst confidence in the stock’s valuation. Molina Healthcare (NYSE:MOH) Price Target Raised to $205.00 at Truist Financial
- Positive Sentiment: Robert W. Baird issued a positive forecast for Molina Healthcare, adding to the list of favorable Wall Street views around the shares. Robert W. Baird Issues Positive Forecast for Molina Healthcare (NYSE:MOH) Stock Price
- Positive Sentiment: Zacks Research nudged its FY2026 earnings estimate higher to $5.22 per share, suggesting near-term earnings expectations are still constructive despite other revisions. Are Investors Undervaluing Molina Healthcare (MOH) Right Now?
- Neutral Sentiment: Molina Healthcare and The MolinaCares Accord donated $120,000 to support programming for young adults with disabilities, a positive corporate citizenship move but unlikely to materially affect earnings. Molina Healthcare and The MolinaCares Accord Donate $120,000 to Support Programming for Young Adults with Disabilities
- Negative Sentiment: Jeff D. Barlow sold 17,811 shares valued at about $3.3 million, trimming his stake by roughly 21%, which can weigh on investor sentiment even when the sale is routine. SEC filing for Jeff D. Barlow insider sale
- Negative Sentiment: Several Zacks Research updates lowered earnings estimates for 2026, 2027, and FY2028, reflecting some caution around Molina Healthcare’s future profitability. Zacks estimate revisions for Molina Healthcare
Hedge Funds Weigh In On Molina Healthcare
Several institutional investors have recently added to or reduced their stakes in MOH. Baird Financial Group Inc. bought a new position in Molina Healthcare during the first quarter valued at about $210,000. NewEdge Advisors LLC grew its position in Molina Healthcare by 33.4% during the first quarter. NewEdge Advisors LLC now owns 1,106 shares of the company's stock valued at $364,000 after buying an additional 277 shares during the period. Jones Financial Companies Lllp grew its position in Molina Healthcare by 713.3% during the first quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company's stock valued at $544,000 after buying an additional 1,448 shares during the period. Goldman Sachs Group Inc. grew its position in Molina Healthcare by 19.4% during the first quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company's stock valued at $82,172,000 after buying an additional 40,531 shares during the period. Finally, Woodline Partners LP bought a new position in Molina Healthcare during the first quarter valued at about $1,541,000. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Company Profile
(
Get Free Report)
Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.
The company traces its roots to the early 1980s, when Dr.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
